Literature DB >> 3121353

The pharmacodynamic and pharmacokinetic interaction of flecainide acetate with propranolol: effects on cardiac function and drug clearance.

J L Holtzman1, D C Kvam, D A Berry, L Mottonen, G Borrell, L I Harrison, G J Conard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3121353     DOI： 10.1007/bf00610389

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  12 in total

1.  A critical review of the systolic time intervals.

Authors:  R P Lewis; S E Rittogers; W F Froester; H Boudoulas
Journal:  Circulation       Date:  1977-08       Impact factor: 29.690

2.  Bedside technics for the evaluation of ventricular function in man.

Authors:  A M Weissler; W S Harris; C D Schoenfeld
Journal:  Am J Cardiol       Date:  1969-04       Impact factor: 2.778

Review 3.  Drug therapy. Flecainide.

Authors:  D M Roden; R L Woosley
Journal:  N Engl J Med       Date:  1986-07-03       Impact factor: 91.245

Review 4.  Adverse reactions with calcium antagonists.

Authors:  R Krebs
Journal:  Hypertension       Date:  1983 Jul-Aug       Impact factor: 10.190

5.  Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.

Authors:  H J Duff; D M Roden; R J Maffucci; B S Vesper; G J Conard; S B Higgins; J A Oates; R F Smith; R L Woosley
Journal:  Am J Cardiol       Date:  1981-12       Impact factor: 2.778

6.  Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.

Authors:  V Legrand; M Vandormael; P Collignon; H E Kulbertus
Journal:  Am J Cardiol       Date:  1983-02       Impact factor: 2.778

7.  Quantitation of flecainide acetate, a new antiarrhythmic agent, in biological fluids by gas chromatography with electron-capture detection.

Authors:  J D Johnson; G L Carlson; J M Fox; A M Miller; S F Chang; G J Conrad
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

8.  Antiarrhythmic effects of flecainide.

Authors:  P Somani
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

9.  Oral flecainide acetate for the treatment of ventricular arrhythmias.

Authors:  J L Anderson; J R Stewart; B A Perry; D D Van Hamersveld; T A Johnson; G J Conard; S F Chang; D C Kvam; B Pitt
Journal:  N Engl J Med       Date:  1981-08-27       Impact factor: 91.245

10.  Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.

Authors:  M Hodges; J M Haugland; G Granrud; G J Conard; R W Asinger; F L Mikell; J Krejci
Journal:  Circulation       Date:  1982-05       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.